1. A Prospective Study of Azilsartan Medoxomil in the Treatment of Patients with Essential Hypertension and Type 2 Diabetes in Asia. (7th January 2022) Authors: Deerochanawong, Chaicharn; Chang, Kuan-Cheng; Woo, Yu Cho; Lai, Wen-Ter; Chutinet, Aurauma Other Names: Salvetti Massimo Academic Editor. Journal: International journal of hypertension Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Associations of glycemia and lipid levels in pregnancy with dyslipidemia 10–14 years later: The HAPO follow-up study. (March 2022) Authors: Lowe, Lynn P.; Perak, Amanda M.; Kuang, Alan; Lloyd-Jones, Donald M.; Sacks, David A; Deerochanawong, Chaicharn; Maresh, Michael; Ma, Ronald C.; Lowe, William L.; Metzger, Boyd E; Scholtens, Denise M. Journal: Diabetes research and clinical practice Issue: Volume 185(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Basal Insulin Dose Titration for Glycemic Control in Patients With Type 2 Diabetes Mellitus in Thailand: Results of the REWARDS Real-World Study. (July 2020) Authors: Deerochanawong, Chaicharn; Leelawattana, Rattana; Kosachunhanun, Natapong; Tantiwong, Puntip Journal: Clinical medicine insights Issue: Volume 13(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Baseline characteristics of patients initiating insulin treatment for type 2 diabetes in the Western Pacific: Evidence from the VISION Study. (October 2016) Authors: Sheu, Wayne; Deerochanawong, Chaicharn; Mirasol, Roberto; Ozaki, Risa; Wan Mohamed, Wan Mohd Izani; Babineaux, Steven; Lew, Thomas; Jabbar, Abdul Journal: Diabetes research and clinical practice Issue: Volume 120(2016)Supplement 1 Page Start: S106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Biphasic insulin aspart 30 treatment for people with type 2 diabetes: a budget impact analysis based in Thailand. (1st February 2018) Authors: Deerochanawong, Chaicharn; Kosachunhanun, Natapong; Chotikanokrat, Pitthaporn; Permsuwan, Unchalee Journal: Current medical research and opinion Issue: Volume 34:Number 2(2018) Page Start: 369 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial. Issue 3 (11th November 2018) Authors: Bain, Stephen C.; Mosenzon, Ofri; Arechavaleta, Rosario; Bogdański, Pawel; Comlekci, Abdurrahman; Consoli, Agostino; Deerochanawong, Chaicharn; Dungan, Kathleen; Faingold, Maria C.; Farkouh, Michael E.; Franco, Denise R.; Gram, Jeppe; Guja, Cristian; Joshi, Pankaj; Malek, Rachid; Merino‐Torres, J... Journal: Diabetes, obesity & metabolism Issue: Volume 21:Issue 3(2019) Page Start: 499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Current concepts in the management of diabetic polyneuropathy. Issue 4 (11th October 2020) Authors: Ziegler, Dan; Papanas, Nikolaos; Schnell, Oliver; Nguyen, Bich Dao Thi; Nguyen, Khue Thy; Kulkantrakorn, Kongkiat; Deerochanawong, Chaicharn Journal: Journal of diabetes investigation Issue: Volume 12:Issue 4(2021) Page Start: 464 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus living in hot climates. Issue 9 (September 2016) Authors: John, Mathew; Cerdas, Sonia; Violante, Rafael; Deerochanawong, Chaicharn; Hassanein, Mohamed; Slee, April; Canovatchel, William; Hamilton, Gill Journal: International journal of clinical practice Issue: Volume 70:Issue 9(2016) Page Start: 775 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy and safety of gemigliptin as add‐on therapy to insulin, with or without metformin, in patients with type 2 diabetes mellitus (ZEUS II study). Issue 1 (8th October 2019) Authors: Cho, Young Min; Deerochanawong, Chaicharn; Seekaew, Samroeng; Suraamornkul, Swangjit; Benjachareonwong, Sunun; Sattanon, Sarinya; Chamnan, Parinya; Sirirak, Thanitha; Kosachunhanun, Natapong; Pratipanawatr, Thongchai; Suwanwalaikorn, Sompongse; Lee, Woo Je; Kim, Sungrae; Choi, Seonghui; Kang, Eun... Journal: Diabetes, obesity & metabolism Issue: Volume 22:Issue 1(2020) Page Start: 123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial. Issue 3 (March 2023) Authors: Laffel, Lori M; Danne, Thomas; Klingensmith, Georgeanna J; Tamborlane, William V; Willi, Steven; Zeitler, Philip; Neubacher, Dietmar; Marquard, Jan; Bardymova, Tatiana; Barrientos Perez, Margarita; Bethin, Kathleen; Bjornstad, Petter; Bondar, Irina; Chen, Mimi; Choi, Jin-Ho; Clements, Mark A; Col... Journal: Lancet Issue: Volume 11:Issue 3(2023) Page Start: 169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗